lunes, 17 de junio de 2024

Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial

https://www.thelancet.com/collections/oncology?dgcid=hubspot_email_infocusalerts-oncology_feature&parent=001611&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-oncology&utm_medium=email&_hsenc=p2ANqtz-8dpy3DPZVDKva09yLe3fqC5Ok1p-hOCIkW-dSE1VikOnLbHlPp5zZFd2K-CQXNPE1Z5flahT2170i6seevaELMUkiHeA&_hsmi=311748437&utm_content=311229495&utm_source=hs_email

No hay comentarios:

Publicar un comentario